My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

State Bank of Bikaner and Jaipur announces change in directorate
Dec 01,2016

State Bank of Bikaner and Jaipur announced that the change of directorate has taken place on the Board of the Bank.

Sandeep Bhatnagar, Deputy General Manager (OSD), A&S Dept, State Bank of India, nominated as Director on the Board of the Bank under Section 25(1)(c) of the SBI (SB) Act, 1959 with effect from 21 November 2016 in place of R.N. Sahay.

Powered by Capital Market - Live News

Bharat Heavy Electricals commissions 1st unit of Pulichintala Hydroelectric project
Dec 01,2016

Bharat Heavy Electricals has successfully commissioned the first unit of the 4x30 MW Pulichintala Hydroelectric project in the State of Telangana. The greenfield project is being set up by TSGENCO in Guntur district of Telangana on the river Krishna.

Powered by Capital Market - Live News

Career Point receives order from Office of DEO, Korba, Chhattisgarh
Dec 01,2016

Career Point has been given a work order by Office of District Education Officer, Korba, Chhattisgarh to provide tutorial services for Pre-Engineering and Pre-Medical test preparation courses. As per the contract, Career Point will be offering school integrated residential coaching for class 11th and 12th students for two academic sessions 2016-17 and 2017-18. The DEO Korba shall provide all infrastructure for the classes to be conducted by Career Point.

Powered by Capital Market - Live News

Advanced Enzyme Technologies MD to be awarded Leader of the Decade Award
Dec 01,2016

Advanced Enzyme Technologies announced that Chandrakant Rathi, Managing Director has to receive the prestigious Biotech Leader of the Decade Award at Pharma Leaders 2016 Annual Power Brand Awards.

Powered by Capital Market - Live News

Moodys: Stable outlook for Asia Pacific power sector reflects consistent regulatory returns, manageable cost increases
Dec 01,2016

Moodys Investors Service says that the stable outlook for the power sector in Asia Pacific over the next 12-18 months is mainly underpinned by consistent regulatory returns and Moodys expectation of manageable increases in fuel costs over the same period, as well as the absence of significant changes to regulatory environments.

Transparent tariff-setting mechanisms will continue to benefit the regulated power utilities in Australia, Hong Kong and Singapore, says Mic Kang, a Moodys Vice President and Senior Analyst.

As for other power companies operating in weaker tariff systems n++ specifically those with a lower ability to recover increased costs n++ the low likelihood of a steep rise in fuel costs should generally result in continued stable business conditions over the next 12-18 months, adds Kang.

Moodys outlook reflects its expectations for fundamental business conditions in the power industry across Asia Pacific over the next 12-18 months.

Moodys report points out that stable industry conditions will in general support the credit metrics of most Moodys-rated power companies across Asia Pacific, despite increasing environmental compliance costs associated with government-led decarbonization initiatives, and growing competitive pressure stemming from new renewable and baseload power plant capacity.

In addition, Moodys believes that most power companies can fund cash shortfalls through debt market issuance, while state-controlled power utilities will continue to benefit from strong government support.

However, many thermal power generators will face medium- to long-term pressure, because of lower dispatch volumes n++ as low marginal cost renewable energy production ramps up n++ and/or increased investments to meet environmental regulations, which may not be fully compensated for through timely tariff adjustments in many countries.

Sector reforms in China (Aa3 negative), Japan (A1 stable) and Korea (Aa2 stable) will have a manageable effect on the operations of power companies during the outlook period. But these reforms will create increasingly challenging business conditions over time, by growing competition and/or potentially reducing the likelihood of extraordinary government support for state-controlled companies.

Thirty nine (74%) of Moodys-rated power companies in Asia Pacific demonstrate ratings with stable or positive outlooks, mainly reflecting broadly unchanged fundamental business conditions, financial profiles consistent with Moodys rating expectations, and/or the positive outlook on a parents rating.

The remaining 14 companies (26%) n++ a majority of which are Chinese power companies and, to a lesser extent, Japans power utilities n++ have ratings which carry negative outlooks or are on review for downgrade.

The negative outlooks or ratings which are on review for downgrade in relation to Chinas power companies are mainly due to the negative outlook on Chinas Aa3 sovereign rating, and the companies weakening credit fundamentals.

Moodys believes Chinas coal-oriented power companies will face greater challenges than those in other regions. Moodys assessment is based on the rapid pace of renewable development in the country n++ which will increase energy supply n++ and an increase in fuel costs, reflecting the recovery in thermal coal prices in the second half of 2016, amid potential delays in the companies ability to pass through such additional costs.

The negative outlooks on the ratings of some Japanese power utilities mainly reflect uncertainty over the timing of restarts of nuclear reactors, given that a sustained recovery in their credit metrics to a large degree depends on their resuming operations.

Meanwhile, Moodys has changed the outlook for Indias (Baa3 positive) power sector to stable from negative, because the increased domestic production of coal will ease constraints on fuel supply, and the Indian governments debt restructuring of the financially weak distribution utilities will likely improve their financial capacity to make timely payments to power generators.

Powered by Capital Market - Live News

Hindustan Construction Company leads gainers in A group
Dec 01,2016

Hindustan Construction Company (HCC) jumped 17.25% to Rs 40.10 at 13:35 IST after the company said it will receive arbitral award payment of approximately Rs 2000 crore from NHPC and NHAI within 4 to 6 weeks. The stock topped the gainers in the BSEs A group. On the BSE, 1.12 crore shares were traded on the counter so far as against the average daily volumes of 8.71 lakh shares in the past two weeks.

MMTC galloped 12.87% at Rs 51.75. The stock was second biggest gainer in A group. On the BSE, 12.05 lakh shares were traded on the counter so far as against the average daily volumes of 1.26 lakh shares in the past two weeks.

Balkrishna Industries spurted 13.23% to Rs 1,125.50. The stock was third biggest gainer in A group. On the BSE, 76,000 shares were traded on the counter so far as against the average daily volumes of 7,556 shares in the past two weeks.

Hathway Cable & Datacom gained 8.71% at Rs 37.45. The stock was fourth biggest gainer in A group. On the BSE, 2.63 lakh shares were traded on the counter so far as against the average daily volumes of 64,000 shares in the past two weeks.

Aban Offshore rose 5.67% to Rs 250.50. The stock was fifth biggest gainer in A group. On the BSE, 9.28 lakh shares were traded on the counter so far as against the average daily volumes of 3.35 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Steel Strips Wheels announces wheel rim sales
Dec 01,2016

Steel Strips Wheels has achieved total wheel rim sales of 11.99 lakh in November 2016 compared to 10.52 lakh in November 2015. In terms of value, the company achieved gross turnover of Rs 128.62 crore (growth of 22%) and net turnover of Rs 115.25 crore (growth of 22%) in November 2016 compared turnover achieved in November 2015.

Powered by Capital Market - Live News

Religare Enterprises shifts registered office
Dec 01,2016

Religare Enterprises has changed its registered office to 2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi - 110019 with effect from 01 December 2016.

Powered by Capital Market - Live News

Lupin and Eli Lilly expand partnership in India
Dec 01,2016

Lupin and Eli Lilly and Company (India) announced an expansion of their partnership in India with the launch of Eglucent, a new brand of Lillys rapid action insulin analog Lispro.

According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacturing and import.

Powered by Capital Market - Live News

Apollo Hospitals Enterprise provides update on Apollo Health and Lifestyle
Dec 01,2016

Apollo Hospitals Enterprise announced that the International Finance Corporation along with its associated entity, has made a primary equity infusion of Rs 450 crore thereby acquiring a 29.03% stake in Apollo Health and Lifestyle, earlier a wholly owned subsidiary of the Company.

Powered by Capital Market - Live News

Suraj Products temporarily suspends operation of Blast Furnace
Dec 01,2016

Suraj Products announced that due to higher input prices, the Company has suspended operation of Blast Furnace temporarily from 30 November 2016.

Powered by Capital Market - Live News

Toll Collection to Resume on National Highways from Midnight of 2nd December
Dec 01,2016

The collection of toll at all Toll Plazas on National Highways across the country will resume from the midnight of 2nd December, 2016. The Government is taking several steps to ensure smooth movement of traffic along the highways.

All Toll Plazas have been equipped with adequate numbers of POS ( Swipe machines) through which people can make payments using their credit or debit cards. Toll fee can also be paid through pre-paid instruments (electronic wallets)

In addition to the above electronic payment methods, the Government is also encouraging people to buy the RFID based FASTags introduced by the Ministry of Road Transport and Highways to enable cashless payments at Toll Plazas. The FASTags can be stuck on to the windshield of the vehicle, and toll payments are made directly from the pre-paid account linked to it. Arrangements for sale of the FASTags are also being made at selected Toll Fee Plazas. The immediate use of FASTags will entail a 10 percent discount on the toll fee, in addition to faster movement through dedicated lanes at the Toll Plazas.

As for making cash payments, the highway users are being requested to carry adequate change with them to avoid delay. The old Rs 500 notes will be accepted till the midnight of December 15, but this will only be for purchasing FASTags and for making toll payments of more than Rs 200.

Officers and representatives of the National Highways Authority of India are being deployed at all Toll Plazas to ensure smooth operations. Their contact details will be displayed at the Toll Plazas.

Powered by Capital Market - Live News

RBIs Liquidity Measures to Continue; Drag Banks Near-term Profitability
Dec 01,2016

India Ratings and Research (Ind-Ra) estimates excess cash reserve ratio (CRR) requirement will additionally cost the banking system INR10.5bn on a monthly basis. The agency believes the relief from the Reserve Bank of India (RBI) would come in a staggered manner, as relieving this high quantum of liquidity all at once will come with challenges.

Unwinding of CRR Hike to be Slow: In Ind-Ras opinion, normalisation of the CRR requirement will be gradual and staggered, as the RBI may exercise caution before releasing the mopped up INR3trn to banks. The persistence of the surplus liquidity conditions will lead the RBI to evaluate alternatives available for liquidity sterilisation. Ind-Ra continues to believe cash management bills can effectively manage the liquidity - owing to their short tenor and consistency with the monetary policy stance.

Floor Placed on Bond Yields: Ind-Ra believes that the RBIs decision to mop up excess liquidity will ensure a floor is put on bond yields. The shorter end of the yield curve is likely to underperform the longer end, as outsized impact will be felt on the former. The longer end of the curve will focus on the evolving global conditions and also upcoming RBIs monetary policy review.

Monetary Policy Transmission to be Impeded: Ind-Ra expects banks to be more proactive in bringing down their term deposit rates, as the increase in CRR requirement creates a drag on the short-term profitability of banks. The move, which is temporary in nature, does not impair the longer term profitability of banks, but induces a larger negative carry on CRR in the computation of the marginal cost-based lending rate (MCLR). In Ind-Ras view, the offsetting impact of a larger negative carry on CRR compared with cheaper deposits would restrict any significant downward movement of MCLR, hampering smooth monetary transmission.

Powered by Capital Market - Live News

Volumes jump at Pfizer counter
Dec 01,2016

Pfizer clocked volume of 55,000 shares by 12:52 IST on BSE, a 37.68-times surge over two-week average daily volume of 1,000 shares. The stock rose 1.29% to Rs 1,853.30.

United Breweries notched up volume of 2.27 lakh shares, a 33.01-fold surge over two-week average daily volume of 7,000 shares. The stock fell 1.53% to Rs 863.60.

Suyog Telematics saw volume of 5.84 lakh shares, a 23.04-fold surge over two-week average daily volume of 25,000 shares. The stock rose 5.62% to Rs 470.

Hindustan Construction Company (HCC) clocked volume of 1.09 crore shares, a 12.58-fold surge over two-week average daily volume of 8.71 lakh shares. The stock rose 16.81% to Rs 39.95.

Housing Development Finance Corporation (HDFC) saw volume of 8.98 lakh shares, a 11.39-fold rise over two-week average daily volume of 79,000 shares. The stock rose 0.89% to Rs 1,276.

Powered by Capital Market - Live News

Lupin heads north after expanding partnership with Eli Lilly in India
Dec 01,2016

The announcement was made during market hours today, 1 December 2016.

Meanwhile, the S&P BSE Sensex was up 22.51 points or 0.08% at 26,675.32.

On the BSE, 51,000 shares were traded on the counter so far as against the average daily volumes of 99,940 shares in the past one quarter. The stock had hit a high of Rs 1,537 and a low of Rs 1,500 so far during the day. The stock had hit a 52-week high of Rs 1,911.55 on 9 February 2016. The stock had hit a 52-week low of Rs 1,294.05 on 29 March 2016. The stock had outperformed the market over the past one month till 30 November 2016, sliding 0.97% compared with the Sensexs 4.57% fall. The scrip had also outperformed the market in past one quarter, declining 0.42% as against the Sensexs 5.96% fall.

The large-cap company has equity capital of Rs 90.27 crore. Face value per share is Rs 2.

Eglucent is a new brand of Eli Lilly and Company (India)s (Lilly) rapid-acting insulin analog Lispro. It is indicated for the treatment of patients with diabetes mellitus. According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for manufacuring and import. Lilly will continue to sell Lispro under the brand name Humalog through its existing channels.

Lupin had earlier collaborated with Lilly (July 2011) to promote and distribute Lillys Huminsulin range of products in India and Nepal.

Lupins consolidated net profit jumped 57.8% to Rs 662.19 crore on 31.9% rise in net sales to Rs 4211.18 crore in Q2 September 2016 over Q2 September 2015.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the cardiovascular, diabetology, asthma, pediatric, central nervous system (CNS), GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.

Powered by Capital Market - Live News